首页> 外国专利> DIABETES MANAGEMENT SYSTEM WITH AUTOMATIC BASAL AND MANUAL BOLUS INSULIN CONTROL

DIABETES MANAGEMENT SYSTEM WITH AUTOMATIC BASAL AND MANUAL BOLUS INSULIN CONTROL

机译:糖尿病管理系统具有自动基底和手动推注胰岛素控制

摘要

Systems and methods for diabetes management with automatic basal and manual bolus insulin control are presented. An exemplary system includes a delivery device, a glucose sensor, and a controller. The delivery device delivers insulin and the glucose sensor measures glucose levels of the subject. A basal insulin dose is calculated using a model predictive control algorithm and physiological data of the subject including desired glucose levels, amounts of the delivered insulin and the measured glucose levels. A manual bolus insulin dose is initiated by the subject. The manual bolus insulin dose is modified based on one or both of the model predictive control algorithm and the physiological data of the subject. A total insulin dose is determined based on the modified manual bolus insulin dose and the calculated basal insulin dose, and delivered to the subject.
机译:提出了具有自动基础和手动推注胰岛素控制的糖尿病管理的系统和方法。 示例性系统包括递送装置,葡萄糖传感器和控制器。 递送装置提供胰岛素,葡萄糖传感器测量受试者的葡萄糖水平。 使用包括所需葡萄糖水平的型号预测性控制算法和病例的生理数据来计算基础胰岛素剂量,包括所需的胰岛素的量和测量的葡萄糖水平。 手动推注胰岛素剂量由受试者引发。 基于模型预测控制算法和受试者的生理数据进行修改手动推注胰岛素剂量。 基于修饰的手动推注胰岛素剂量和计算的基础胰岛素剂量和递送至受试者,确定总胰岛素剂量。

著录项

  • 公开/公告号US2022031950A1

    专利类型

  • 公开/公告日2022-02-03

    原文格式PDF

  • 申请/专利权人 LIFESCAN IP HOLDINGS LLC;

    申请/专利号US202117503720

  • 发明设计人 DANIEL FINAN;THOMAS MCCANN;

    申请日2021-10-18

  • 分类号A61M5/172;A61M5/178;A61M5/142;

  • 国家 US

  • 入库时间 2022-08-24 23:37:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号